The fact that higher C-Alb values were associated with both CKD progression and mortality means that patients with the highest C-Alb values required dialysis sooner and expired sooner than other CKD stage 4–5 patients who otherwise had equivalent measures of kidney function. This evidence concerns the gene ALB and chronic kidney disease.